The ARUK-DMT Clinical Research Fellowship is intended for clinical researchers, including trainee Old Age/General Psychiatrists, Neurologists, Clinical Psychologists and similar specialists, who may or may not have a PhD. For a detailed description of the skills and training you will be expected to demonstrate, please read our Early Career Researcher Framework.
It is preferable but not essential that the prospective Clinical Fellow would have delivered previous research project(s) on vascular dementia with impactful outputs, such as publications and conference presentations, and demonstrate an upward trajectory. The prospective Clinical Fellow should be starting to accumulate a tool-box of skills that will serve as a strong basis for future independent research activity, whilst being increasingly recognised for their specialist expertise.
Researchers who hold tenure are not eligible to apply.
The lead applicant and point of contact must be based in a UK academic/research institution. However, the application can include researchers or institutions outside the UK.
The Fellow is required to have secured at least one Supervisor, an established senior investigator in the institution where the Fellowship is to be held. At least one Supervisor must be clinically qualified (UK MRCP, MRCPsych, BPS accreditation, or equivalent) with an honorary clinical contract. At least one Supervisor, preferably the lead Supervisor, must have a contract (fixed term or tenure) with the host institution covering the proposed duration of the Fellowship. If the lead Supervisor does not hold either a fixed contract or tenure, the application must include a co-Supervisor that does. The Supervisor(s) will provide the required facilities, have oversight of the Fellow and their research programme, and contribute actively to the training of the Fellow.
The Clinical Fellowship should preferably be applied for by the prospective Fellow. However, prospective Supervisors without a nominated candidate and who plan to recruit a Fellow following a conditional award offer from Alzheimer’s Research UK can apply directly.
If the project requires ethical approval and/or Home Office licences, the award is dependent upon the requisite approvals being granted.
Applications are made via our grant application website.
Grant schemes only appear on this website when the round is open and we are accepting new applications.
Alzheimer’s Research UK and The Dunhill Medical Trust are members of the Association of Medical Research Charities and follow their guidelines for best practice in peer review. Grants are awarded entirely on scientific merit in relation to Alzheimer’s Research UK and The Dunhill Medical Trust’s remit and on the basis of open competition. The quality of the application and applicants is the key determinant of outcome, although the strength of the dementia research environment within the institution is also considered.
Grant Review Board (GRB) members from Alzheimer’s Research UK and The Dunhill Medical Trust will be asked to read a subset of applications related to their area of expertise and provide a score based on whether an application should proceed to the next stage of review.
Applications requesting funding of over £50,000 per year are subjected to external peer review. Applications are sent to researchers in the UK and worldwide who specialise in the area of the application, but who do not have a conflict of interest and are not a member of the review boards. The comments made by the external reviewers are made available to the review board members.
The applicants are provided with anonymised copies of the external reviews and given the opportunity to provide a written response.
Applications for research studies that involve human subjects require lay review. Applicants are requested to complete a lay summary of their application which is sent to lay review volunteers for comments. The comments made by lay reviewers are made available to the GRB members.
Discussion in meeting
Each application is allocated to two GRB members of Alzheimer’s Research UK and a member of the GRB from The Dunhill Medical Trust, based roughly on their areas of expertise. These members will present the application to the rest of the board, including any relevant information from external reviews or applicant responses. A short discussion will follow before the GRB score the application and decide whether or not to call the prospective Fellow to interview.
Interviews normally take place in the fortnight following the GRB meeting. The interview panel comprises a subset of the GRB from Alzheimer’s Research UK and The Dunhill Medical Trust and the Director of Research at ARUK. The prospective Fellow will be asked to give a 15-20 minute PowerPoint presentation on their work.
Those applications recommended for funding by the GRB are presented to the trustees of the two charities for final approval.
Applicants will be notified of the decision early July 2019
The terms and conditions of grant differ for each grant scheme and contracts are drawn up individually once the grants have been awarded.
View an example award letter and contract for a Clinical Research Fellowship grant.
All grant holders are expected to report on the progress of their project on a regular basis. The reports will be shared with The Dunhill Medical Trust. Read more about our reporting requirements on the measuring impact page.
Download our GDPR statement that explains how Alzheimer’s Research UK Research Team handles personal data about our grant applications and the rights that applicants have under data protection law. In this Notice, we refer to this type of information as “Applicant Data”.
This statement applies to applications submitted via Grant Tracker. It also applies to applications summitted via other means, such as by post and email.
Download GDPR statement